RareFinance peopleInnovationCareers PipelineCollaborationAdvance treatment SVGOMG The best SVG optimizer and minifier Open SVG Paste markup Demo Contribute SVGOMG provides you several options to clean and compress your SVG files. Clean up, remove, merge, minify. Upload or copy the source of your SVG to get started! 947 bytes → 267 bytes 28.19% Skip to main contentSkip to navigationSkip to search
HNSA   ( ,  %) SEK
Quotes are delayed 15 minutes

2024

7 Oct 2024, 10:00
Hansa Biopharma’s HNSA-5487 Achieved Rapid and Highly Robust IgG Reduction by More Than 95% and Clear Redosing Potential in First-in-Human Trial
3 Oct 2024, 07:00
Hansa Biopharma to host Q3 2024 interim results conference call
5 Sep 2024, 11:00
Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
23 Aug 2024, 18:00
Hansa Biopharma Announces Departure of Chief Commercial Officer, Matthew Shaulis
18 Jul 2024, 07:00 | Regulatory
Hansa Biopharma Reports Second Quarter 2024 Financial Results and Business Update
3 Jul 2024, 07:00
Hansa Biopharma to host Q2 2024 interim results conference call
28 Jun 2024, 07:00 | Regulatory
Hansa Biopharma: increase in number of shares and votes
27 Jun 2024, 15:00 | Regulatory
Bulletin from the Annual General Meeting in Hansa Biopharma AB (publ)
Load more

E-mail

Sign up to receive updates on the latest company news and filings

Choose type

I consent to Hansa Biopharma handling my personal data. See our Privacy Policy for information about how we handle personal data.

Thank you. You will get an e-mail message to activate your subscription.